Results 111 to 120 of about 2,685,093 (235)

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Antioxidant and Degradable Poly(Squaryl Thioester) Networks

open access: yesMacromolecular Materials and Engineering
Squaric acid, hence the name, is almost square‐shaped, and this intriguing moiety has recently attracted considerable attention from the polymer community.
Emre Akar   +4 more
doaj   +1 more source

Changes in Immune‐Inflammation Status and Prognosis in Pregnancy‐Related Cerebral Venous Thrombosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Distinguishing pathological changes from physiological adaptations in pregnancy‐related cerebral venous thrombosis (CVT) is clinically challenging. This study aimed to characterize coagulation, immune‐inflammation, and dehydration status in these patients and assess their prognostic value.
Xiaoming Zhang   +7 more
wiley   +1 more source

Early Clinical and Cerebrospinal Fluid Predictors of 1‐Year Recurrence in Autoimmune GFAP Astrocytopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune glial fibrillary acidic protein astrocytopathy (GFAP‐A) is an inflammatory central nervous system disorder with variable outcomes. Relapse occurs in a subset of patients, but early predictors remain unclear. We aimed to identify admission‐available features associated with 1‐year recurrence and develop an interpretable ...
Qingting Hong   +10 more
wiley   +1 more source

Dynamic Changes in Serum Glial Fibrillary Acidic Protein Levels Predicts Early Neurological Deterioration After Intravenous Thrombolysis in Minor Stroke

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Minor strokes may be associated with early neurological deterioration (END) and disabilities. The objective was to investigate the role of serum glial fibrillary acidic protein (GFAP) levels in predicting END. Methods Data originated from a multicenter cohort study conducted prospectively.
Jie Zhou   +45 more
wiley   +1 more source

Dependence of dielectric constant and loss tangent on electric field in antiferroelectric squaric acid crystal [PDF]

open access: yes, 2016
The double-time thermal Green function method with the symmetric and antisymmetric decoupling scheme and modified pseudospin model proposed by Li and Qin for squaric acid have been used in present study to discuss the effect of electric field on some ...
Upadhyay, T C, Khanduri, Prabhat Chandra
core  

Rheumatoid Arthritis and Coronary Artery Calcium Progression: A Case Cohort Analysis From ELSA‐Brasil

open access: yesArthritis Care &Research, EarlyView.
Objective To investigate the association between rheumatoid arthritis (RA) and coronary artery calcium (CAC) prevalence, incidence, and progression over four years in adults without prior cardiovascular disease. Methods A case‐cohort study within the Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil) included 585 participants (86 patients with ...
Patrícia Fonseca Estrada   +7 more
wiley   +1 more source

Synthesis and characterization of symmetric derivatives of squaric acid

open access: yes, 2020
U cilju optimizacije koraka u pripravi derivata skvareinske kiseline provedena je sinteza simetričnih skvareinskih sustava. Prvi korak sinteze uključuje reakciju aminacije aril-halogenida i amina, koja je uspješno provedena uz n-BuLi u bezvodnom eteru ...
Posavec, Pamela
core   +1 more source

Synthesis of Squaric Acid Monoamides as Building Blocks for Drug Discovery

open access: yesSynOpen, 2023
Nathan Long   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy